Cadila Pharmaceuticals website gets AI-powered digital upgrade
Cadila Pharmaceuticals launches AI-enabled website with new search and career tools
Ahmedabad, August 21, 2026: Cadila Pharmaceuticals has launched a redesigned official website with an AI-powered chatbot and a new search system, giving patients, healthcare professionals, business partners and job seekers a quicker way to find information about the company and its products.
The Ahmedabad-based pharmaceutical company said the new website, www.cadilapharma.com, has been rebuilt for use on desktop computers, tablets and smartphones. The company has also changed the site’s navigation and search features so visitors can reach product, business and career information with fewer steps.
The AI chatbot is one of the main additions. According to Cadila Pharmaceuticals, it can answer user queries and help visitors find information about products, services and employment opportunities. The company has not said that the chatbot is intended to replace medical advice from doctors or other qualified healthcare professionals.
For patients and healthcare professionals, the website brings together information on Cadila Pharmaceuticals’ medicines and areas of work. These include gastroenterology, oncology, cardiology and diabetology. The company also operates in areas such as neurology, gynaecology, orthopaedics, dermatology, respiratory care, vaccines, anti-infective medicines, paediatric care and critical care.
The site also carries information about the company’s Active Pharmaceutical Ingredients, or APIs, and its CDMO partnerships. APIs are the ingredients that give medicines their therapeutic effect, while CDMO services involve pharmaceutical development and manufacturing work carried out for other companies.
For job seekers, Cadila has expanded its “Life at Cadila” section. The company says the section gives candidates information about its workplace and available career opportunities. Cadila Pharmaceuticals is currently listed by Great Place to Work India as a certified organisation in the biotechnology and pharmaceuticals category for the November 2025 to November 2026 period.
Jatin Shah, COO, Generics & Institution Business, Cadila Pharmaceuticals Ltd., said, “As we build on our legacy of over seven decades, adapting AI-powered technology into our digital ecosystem reflects our unwavering commitment to healthcare innovation. This revamped platform is thoughtfully designed to make key information accessible, fast, and transparent for all our stakeholders. By leveraging modern digital tools, we continue to reinforce our mission of delivering trusted, high-quality healthcare solutions that improve lives globally.”
The website launch comes as Cadila Pharmaceuticals marks 75 years in the pharmaceutical business. The company traces its origins to Indravadan A. Modi and says Cadila Laboratories was founded on March 13, 1952. Its own historical records also note that the business was restructured and renamed Cadila Pharmaceuticals in 1995.
Cadila’s history is closely linked with the development of India’s domestic pharmaceutical sector. The company says Modi began working in the pharmaceutical business at a time when India depended heavily on imported medicines. Its history includes the establishment of manufacturing facilities in Gujarat and later expansion into other countries.
The company now describes itself as one of India’s largest privately held pharmaceutical companies, with its headquarters in Ahmedabad. Its current website says it supplies medicines across 100 countries and has more than 850 products covering 45 therapies and 12 specialities.
Research and manufacturing remain major parts of the business. Cadila’s corporate information says its work covers formulations, APIs and research and development, while its product portfolio extends across several medical fields. The company has also reported a long record of work in drug development and manufacturing, including medicines for cardiovascular disease, cancer, tuberculosis and other conditions.
The website therefore serves more than a marketing role. It is also a public information point for a company whose operations involve patients, doctors, distributors, business partners and potential employees in several countries. For these users, the quality of information available online can affect how quickly they find product details, contact information, business services or employment opportunities.
There is also a practical reason for pharmaceutical companies to pay closer attention to their digital services. Patients and healthcare professionals increasingly use company websites to check medicine information, therapeutic areas and professional resources before contacting an organisation directly. A search system that can locate the right page quickly can reduce the time spent looking through large corporate websites.
For Cadila Pharmaceuticals, the new website also brings its 75-year history into a digital setting. The company began with a focus on making medicines in India and has since developed a business covering research, manufacturing and sales in international markets.
The company has said the new website is designed to work across smartphones, tablets and computers, reflecting the way many users now access information. Its AI chatbot adds another route for visitors who may prefer asking a question rather than searching through several pages.
The real test will be how accurately and usefully the new system handles those questions. For a pharmaceutical company, clear product information matters because visitors may include patients and healthcare professionals looking for medical information. The website can make information easier to find, but decisions about treatment and medicines still require qualified medical advice.
With the launch, Cadila Pharmaceuticals has added a new digital layer to a company that has spent more than seven decades building its pharmaceutical operations. The website now brings its medicines, research activities, business services and career information together in one online destination.
